The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSQN.L Regulatory News (SQN)

  • There is currently no data for SQN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on AD Plant Valuation & Strategic Review

13 Feb 2020 07:00

RNS Number : 8206C
SQN Asset Finance Income Fund Ltd
13 February 2020
 

13 February 2020

 

SQN Asset Finance Income Fund Limited

("SQN" or the "Company")

 

LEI: 2138007S3YRY3IUU4W39

 

Updates on the Anaerobic Digestion ("AD) plants valuation process

and the Company's strategic review process.

 

 

Further to the announcements made on 20th and 24th January 2020, the Board of the Company is pleased to announce that it has appointed KPMG, Ireland to act for the Company in reviewing the valuation model used for the 6 AD plants. The Board anticipates that this review will be completed during March 2020 and will make an announcement as soon as practicable thereafter.

 

Accordingly, shareholders should note that the Net Asset Valuation for the Ordinary Shares for 31st December 2019 and for 31st January 2020 will be delayed until after this review is completed. The Net Asset Value of the C Shares for 31st January 2020 is anticipated to be released towards the end of February, as usual.

 

In addition, the Board has commenced its strategic review of the Company, including the provision of investment management services. The Board is pleased to advise shareholders that a large number of expressions of interest have been received from a wide range of investment managers. Requests for Proposal have been sent to those managers that the Board feel could be suitable to manage the assets of the Company. Initial meetings with managers are expected to take place in early March 2020 with the process being completed during April 2020, unless the Board determines that there is a requirement for detailed due diligence work, which may cause any announcement to be delayed beyond that date.

 

As previously noted, the Board will be including the current managers, SQN Capital Management LLC and SQN Capital Management (UK) Limited, in this selection process.

 

Until this process has been completed the Board has agreed with the manager that no new investments will be made without prior approval of the Board and only payments covering "business as usual" and agreed existing commitments will be made.

 

The Board will continue to keep shareholders updated through these processes as appropriate.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGPUMCPUPUGQP
Date   Source Headline
17th Jul 20202:58 pmRNSChange of Name
16th Jul 202012:38 pmRNSResult of EGM and Class Meetings
8th Jul 20207:00 amRNSInvestment Update
24th Jun 20207:00 amRNSNet Asset Value(s)
17th Jun 20203:02 pmRNSHolding(s) in Company
16th Jun 20207:00 amRNSContinuation Vote and Publication of Circular
8th Jun 20207:00 amRNSAppointment of Investment Manager
22nd May 20207:00 amRNSNet Asset Value(s)
5th May 202012:03 pmRNSDisclosure of rights attached to listed securities
30th Apr 20207:00 amRNSConclusion of Strategic Review & Change of Manager
24th Apr 20202:23 pmRNSMonthly Net Asset Value and Covid-19 update
14th Apr 202011:35 amRNSHolding(s) in Company
6th Apr 20204:42 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
3rd Apr 20203:21 pmRNSHalf-Yearly Report
1st Apr 20208:51 amRNSHalf-year Report - Delay in publication
31st Mar 20202:13 pmRNSJanuary and February Net Asset Values
31st Mar 20201:01 pmRNSOutcome of KPMG Review & Release of December NAV
24th Mar 20207:00 amRNSMonthly Net Asset Value and Dividend
18th Mar 202011:32 amRNSUpdate on Dividends
18th Mar 20207:00 amRNSForeign Exchange Hedging
5th Mar 20207:00 amRNSConclusion of a further Anaerobic Digestion plant
25th Feb 20207:00 amRNSBoard Responsibilities
21st Feb 20207:00 amRNSNet Asset Value and Dividend
13th Feb 20207:00 amRNSUpdate on AD Plant Valuation & Strategic Review
12th Feb 20207:00 amRNSMarket Update
5th Feb 202011:25 amRNSHolding(s) in Company
28th Jan 202010:08 amRNSStrategic Review Update
27th Jan 202011:40 amRNSHolding(s) in Company
24th Jan 20207:00 amRNSMonthly Net Asset Value and Dividend
24th Jan 20207:00 amRNSStrategic Review
20th Jan 20208:26 amRNSAnaerobic Digestion Assets
2nd Jan 202010:58 amRNSTotal Voting Rights
20th Dec 20197:00 amRNSNet Asset Value and Dividend
11th Dec 20195:43 pmRNSTransaction in Own Shares
9th Dec 20194:46 pmRNSTransaction in Own Shares
5th Dec 20193:51 pmRNSTransaction in Own Shares (Replacement)
4th Dec 20196:00 pmRNSDirectorate Change
4th Dec 20197:30 amRNSTransaction in Own Shares
2nd Dec 20195:01 pmRNSTransaction in Own Shares
28th Nov 20195:30 pmRNSTransaction in Own Shares
22nd Nov 20197:00 amRNSNet Asset Value and Dividend
21st Nov 20194:21 pmRNSResult of AGM and Class Meetings
28th Oct 20194:02 pmRNSNotice of AGM and Class Meetings
28th Oct 20197:00 amRNSMonthly NAV and Dividend
25th Oct 20192:28 pmRNSHolding(s) in Company
8th Oct 20194:38 pmRNSAnnual Financial Report (Replacement)
2nd Oct 201912:01 pmRNSNet Asset Value and Dividend (replacment)
30th Sep 20197:01 amRNSAnnual Financial Report
30th Sep 20197:00 amRNSNet Asset Value and Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.